Abiopharma

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

enGene to Present at the Piper Sandler 37th Annual Healthcare Conference

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

BridgeBio to Participate in December Investor Conferences

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

REGENXBIO to Participate in Upcoming Investor Conference

Unicycive Therapeutics to Participate in Upcoming Investor Events in December

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

Inotiv - Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™